3rd Edition of Cardiology World Conference

September 14-15, 2022 | Virtual Event

September 14 -15, 2022 | Online Event

Cardio 2022

Robert Allan, Speaker at Cardiology Conferences
Keynote Presentation
Robert Allan, Weill Cornell Medical Center, United States

A very large empirical database supports the field known variously as behavioral cardiology, cardiac psychology and psychocardiology.  A PubMed search of the terms “psychosocial factors and cardiovascular disease (CVD)” yields more than 60,000 citations. In 2021, [....] » Read More

Siamak Salavatian, Speaker at Cardiovascular conferences
Keynote Presentation
Siamak Salavatian, University of Pittsburgh, United States

The cardiac autonomic nervous system, which involves the intrinsic cardiac nervous system, intrathoracic extracardiac ganglia, and central nervous system, modulates every aspect of cardiac function. Autonomic imbalance by sympathetic activation and parasympathetic dysfunction inc [....] » Read More

Sekib Sokolovic, Speaker at Cardiovascular Diseases Events
Oral Presentation
Sekib Sokolovic, Sarajevo University Clinical Center, Bosnia and Herzegowina

INTRODUCTION: The post-COVID-19 syndrome is a subacute chronic condition affecting certain recovered patients from the acute viral infection. The most post-covid symptoms resolve after 3 months, but some patients experience continuation of fatigue, shortness of breath, palpitatio [....] » Read More

Ahdy wadie Helmy, Speaker at Cardiology Conferences
Oral Presentation
Ahdy wadie Helmy, Indiana University School of Medicine, United States

Although, short term graft survival is steadily improving, chronic graft failure still represents an important clinical challenge. This is likely to increase as organ transplantation is getting to be a more wide spread practice. As precious as donated organs, the danger of accele [....] » Read More

Amna Ibrahim Al Muaini, Speaker at Cardiology conferences
Oral Presentation
Amna Ibrahim Al Muaini, Tawam hospital, United Arab Emirates

Cardiovascular diseases are a leading cause of death all over the world that affect public health significantly. Many risk factors are associated with cardio vascular disease, however one of the emerging risk factors, that can be managed, and prevented is the drug induced one. Ma [....] » Read More

Fateme Khodadadi, Speaker at Cardiovascular Conferences
Oral Presentation
Fateme Khodadadi, Shiraz University,, Iran (Islamic Republic of)

Clinical parameters used to detect the late stages of hemorrhagic shock (HS) and changes in autonomic nervous system activity (ANS) are an initial response to HS. Therefore, measurement of ANS may be a useful method for identifying the stages and classes of HS. Sprague Dawley ra [....] » Read More

Alireza Malekrah, Speaker at Cardiology Conferences
Oral Presentation
Alireza Malekrah, mazandaran university of medical science , Iran (Islamic Republic of)

Background Apart from junctional rhythms during slow pathway ablation, there is limited knowledge on the junctional tachycardia persisting following the ablation cessation. So, this study aimed to determine the characteristics and significance of this rare arrhythmia.   [....] » Read More

Abhijit Ray, Speaker at Cardiovascular Events
Oral Presentation
Abhijit Ray, FITTO Clinic, India

Polycystic Ovarian Syndrome (PCOS) or Stein-Leventhal Syndrome is the most frequent endocrine illness, with systemic metabolic symptoms and neuroendocrine-immunity disruption commonly affecting 5%–10% of reproductive-age women described by two of the following three charact [....] » Read More

Dae Wook Lee, Speaker at Cardiology Conferences
Oral Presentation
Dae Wook Lee, Novartis Korea , Korea, Republic of

The human genetic techniques including Coding GWAS are generically associated with diseases whereas the expansion of Human Data Ecosystem in multi-geographic regions provide valuable insights on disease specific cohorts and genomic data. The investment on human genome research an [....] » Read More

Gustavo Lionel Knop, Speaker at Cardiovascular Conference
Oral Presentation
Gustavo Lionel Knop, Mayo Clinic, United States

HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal-flow pump has been evaluated in MOMENTUM 3, the largest LVAD trial ever conducted demonstrating excellent survival and safety outcomes with HeartMate 3™ LVAD. It has been pub [....] » Read More

Francesca Leone, Speaker at Cardiology Conferences
Oral Presentation
Francesca Leone, Hull University Teaching Hospitals, United Kingdom

Approximately 1% of patients who undergo coronary artery bypass graft surgery (CABG) may require permanent pacemaker implantation (PPMI). Previous studies have investigated risk factors for PPMI including age, sex and the presence of renal disease. However, we wished to focus on [....] » Read More

Rajini Samuel, Speaker at Cardiovascular Conference
Oral Presentation
Rajini Samuel, Shri Sathya Sai Medical College and Research institute, India

Electrocardiography (ECG) is one of the oldest diagnostic tool in medicine yet its interpretation remains an arduous task. A lot of advancements had come in the ECG machine, yet the basic physics principle of ECG is not clearly understood.  The concept of Einthoven triangle [....] » Read More

Natallia Maroz Vadalazhskaya, Speaker at Speaker for CWC Conference- Natallia Maroz-Vadalazhskaya
Oral Presentation (In-Person)
Natallia Maroz Vadalazhskaya, Belarusian State Medical University, Belarus

Mitral valve insufficiency is a condition which comes from many causes. The quantitative assesment of the regurgitant volume provides an actual estimation of the severity of an intracardiac flow disturbance. In terms of the wide using of new devices and surgical approach the echo [....] » Read More

Sepideh Darbandi, Speaker at Cardiology Conferences
Poster Presentation
Sepideh Darbandi, MercyOne North Iowa Medical Center, United States

Case: Patient is an otherwise healthy 69 year old male with inferior STEMI s/p proximal RCA stent 3 days prior who was discharged in stable condition. Patient had been discharged on aspirin and clopidogrel for dual antiplatelet therapy.  48 hours after discharge, and a total [....] » Read More

Bashar Khiatah, Speaker at Cardiology conferences
Poster Presentation
Bashar Khiatah, Community Memorial Hospital, United States

Background: The natural forces of the lunar cycle and seasonal equinox variation on the heart function affecting mainly patients with heart failure (HF), myocardial infarction, and arrhythmias are unknown and have not been previously studied. This retrospective review invest [....] » Read More

Hafez Golzarian, Speaker at Cardiovascular Conference
Poster Presentation
Hafez Golzarian, Mercy Health St. Rita's Medical Center, United States

Amniotic fluid embolism (AFE) is a rare but potentially fatal complication of pregnancy that accounts for nearly 1 in 5 maternal deaths globally. Of these deaths, nearly half of them occur within one hour of symptom onset. Therefore, prompt and aggressive resuscitation strategies [....] » Read More

D K Satsangi, Speaker at Cardiology Conferences
Cardiomersion Workshop
D K Satsangi, AIIMS, India

Will be Updated Soon...

Vivek Jawali, Speaker at Heart Congress
Cardiomersion Workshop
Vivek Jawali, Fortis Hospital, India

Will be Updated Soon...

Eric Lehr, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Eric Lehr, Swedish Heart and Vascular Institute, United States

Will be Updated Soon...

Eric Lehr, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Eric Lehr, Swedish Heart and Vascular Institute, United States

Will be Updated Soon...

Johannes Bonatti, Speaker at Heart Congress
Cardiomersion Workshop
Johannes Bonatti, University of Pittsburgh Medical Center, United States

Will be Updated Soon...

Tomoko Kato, Speaker at Cardiology Conferences
Cardiomersion Workshop
Tomoko Kato, Juntendo University - Heart Center, Japan

Will be Updated Soon...

Deepak Puri, Speaker at Cardiology conferences
Cardiomersion Workshop
Deepak Puri, Max Healthcare, India

PURPOSE : Heart Team Approach has benefited management of Cardiovascular patients for more than a decade now. We adapted Integrated for the Comprehensive management of Cardiovascular and Thoracic surgery patients from 2011 . However the virtues of this approach were tested to the [....] » Read More

Nidhi Puri, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Nidhi Puri, Dr YS Parmar Government Medical college Nahan, India

Will be Updated Soon...

Amitabh Satsangi, Speaker at Heart Congress
Cardiomersion Workshop
Amitabh Satsangi, Dept of CTVS , AIIMS , India

As the literature lacks reports from Indian subcontinent, the present study was undertaken to understand Indian scenario at initial presentation of Type A Aortic Dissection (TAAD). Materials and method: Records of 162 patients operated for TAAD from June 2014 to June 2019 we [....] » Read More

Surabhi Puri, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Surabhi Puri, AIIMS, India

Cardiovascular disease (CVD) stands at the top of the list of causes of death worldwide. With the epidemiological transition in India, the prevalence of non-communicable diseases, including CVDs, is on the rise. A quarter of the deaths occurring in India can be attributed to CVDs [....] » Read More

Chaitanya Gupta, Speaker at Cardiology Conferences
Cardiomersion Workshop
Chaitanya Gupta, Brij Healthcare, India

Will be Updated Soon...

Neha Chandraker, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Neha Chandraker, Banarsidas Chandiwala Institute of Medical Sciences, India

Coronary Artery Disease, is the leading cause of death globally resulting in over 7 million deaths. Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional protein that is mainly located in the nucleus. APE1 is involved in the base excision [....] » Read More

Krushna Makhwana, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Krushna Makhwana, Lifelink Healthcare, India

Will be Updated Soon...

Vineeta Ahooja, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Vineeta Ahooja, Heart Health Institute - Wayne State University , Canada

Will be Updated Soon...

Sandeep Tirath Laroia, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Sandeep Tirath Laroia, University of Iowa College of Medicine, United States

Will be Updated Soon...

Mitashi Sindhi, Speaker at Heart Congress
Cardiomersion Workshop
Mitashi Sindhi, Activ Physio Hub, India

Will be Updated Soon...

Sonal Chugh, Speaker at Cardiology Conferences
Cardiomersion Workshop
Sonal Chugh, Dr. Sonal's Homeopathy, India

Will be Updated Soon...

Amanvir Kaur, Speaker at Heart Congress
Cardiomersion Workshop
Amanvir Kaur, Infinite Wellness, India

Will be Updated Soon...

Sushil Sehgal, Speaker at Cardiovascular Diseases Events
Cardiomersion Workshop
Sushil Sehgal, Cardiomersion, India

The goal of this presentation is to tell about the benefits of protocols we have made to be followed for the Comprehensive management of patients with cardiovascular disease during Pre-operative , Post-operative  ICU stay as well as In rehabilitation center or for those pati [....] » Read More

Shingarika Guleria, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Shingarika Guleria, Belleza-House of Miracles by Shindsky, India

Will be Updated Soon...

Somya Puri, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Somya Puri, MM MEDICAL COLLEGE, India

INTRODUCTION An integrated approach towards managing a patient or inter speciality co-ordinated approach is characterized by a high level of collaboration and communication among various healthcare professionals in pursuance of complete management of each patient. It involves [....] » Read More

Jyotsana Pandit, Speaker at Heart Congress
Cardiomersion Workshop
Jyotsana Pandit, Sanskriti University, India

Will be Updated Soon...

Tomoko Kato, Speaker at Cardiology Conferences
Cardiomersion Workshop
Tomoko Kato, Juntendo University - Heart Center, Japan

Will be Updated Soon...

Tomoko Kato, Speaker at Cardiology Conferences
Cardiomersion Workshop
Tomoko Kato, Juntendo University - Heart Center, Japan

Will be Updated Soon...

Vinakshi Gomre, Speaker at Cardiovascular Diseases
Cardiomersion Workshop
Vinakshi Gomre, Physician Assistant at Max Healthcare, India

Perioperative nursing care refers to the care rendered by nursing Team during pre-operative, intra-operative and post-operative stay of patients undergoing surgery. A patient undergoes different  experiences during these phases with much stress and anxiety during the hospita [....] » Read More

Deepika Lamba, Speaker at Cardiology Conferences
Cardiomersion Workshop
Deepika Lamba, Government Medical College & Hospital, India

Will be Updated Soon...

Shaurya Pratap Kushwaha, Speaker at Cardiology Conferences
Cardiomersion Workshop
Shaurya Pratap Kushwaha, Medical Officer for Mosaic Wellness, India

In India, the incidence of coronary artery disease and related risk factors has risen dramatically. Coronary artery disease is a major public health concern worldwide. Anthropometric indices such as BMI, WC, WHR, and WHtR are low-cost and simple to measure and track. In many popu [....] » Read More

Jacob Jamesraj, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Jacob Jamesraj, Madras Medical Mission Hospital, India

Will be Updated Soon...

Tanya Bhardwaj, Speaker at Cardiology Conferences
Cardiomersion Workshop
Tanya Bhardwaj, Medical officers in Cardiomersion , India

Will be Updated Soon...

Prabjeet Kaur, Speaker at Cardiology Conferences
Cardiomersion Workshop
Prabjeet Kaur, Cardiologist , India

Will be Updated Soon...

Kusha Korla, Speaker at  Cardiology Conferences
Cardiomersion Workshop
Kusha Korla, Specialist- IPD Analytics, India

Will be Updated Soon...

Vineet Gupta, Speaker at Cardiovascular Conference
Cardiomersion Workshop
Vineet Gupta, Interventional Radiologist & Neuroradiologist, Switzerland

Will be Updated Soon...

MN Mamedov, Speaker at Leading speaker for CWC 2019- MN Mamedov
Keynote Presentation
MN Mamedov, National Research Center for Preventive Medicine, Russian Federation

Aim. To assess the predicted ten-year survival rate and the risk of cardiovascular complications in adult population in the Vladimir region of the Russia. Material and methods. A cross-sectional population study included 1200 men and women aged 30-69 years from 5 cities of the V [....] » Read More

Senay Cetinkaya, Speaker at Speaker for  CWC Conference- Senay Cetinkaya
Keynote Presentation
Senay Cetinkaya, Cukurova University, Turkey

Growth is the increase in body volume and mass due to the increase in cell number and size. Growth is determined in the intrauterine period by gender, intrauterine environment, intrauterine infections, maternal chronic diseases, genetic factors, chromosomal diseases, skeletal dys [....] » Read More

Abdul Ghafoor zarmalwal, Speaker at Cardiovascular Diseases Events
Oral Presentation
Abdul Ghafoor zarmalwal, FMIC hospital Kabul,, Afghanistan

Abstract: The primary causes of premature death are cardiovascular diseases, Cardiovascular diseases also led to around 17.9 million (32.1%) deaths in 2015 (8). Left ventricle dysfunction is the most recurrent consequence of ST-elevated myocardial infarction and still, it is a po [....] » Read More

Ellen Z Lu , Speaker at Cardiovascular conferences
Oral Presentation
Ellen Z Lu , Newton South High School, United States

Objective: To evaluate the prospective association of waist-to-thigh ratio (WTR) with cardiovascular disease (CVD) mortality and compare with body mass index (BMI), waist circumference (WC), thigh circumference (TC), and waist-height ratio (WHtR). Methods: The study [....] » Read More

Mikhail Rudenko, Speaker at Cardiovascular Conference
Oral Presentation
Mikhail Rudenko, Russian New University, Russian Federation

Listeners will learn about a fundamental discovery of a new blood flow mode with low friction due to structuring the flow in each cardiac cycle in the form of alternating rings of blood cells and plasma, which is accurately described mathematically by the authors. This radically [....] » Read More

Alireza Razavi, Speaker at Cardiology Conferences
Oral Presentation
Alireza Razavi, Mazandaran University of Medical Sciences, Iran (Islamic Republic of)

Introduction Efficacious therapies are urgently required to tackle the coronavirus disease 2019 (COVID-19). This trial aims to evaluate the effects of atorvastatin in comparison with standard care for adults hospitalized with COVID-19. Methods We conducted a randomized control [....] » Read More

Ramachandran Muthiah , Speaker at Cardiovascular Conference
Oral Presentation
Ramachandran Muthiah , MGR medical university, India

The rising incidence of CAD is a new phenomenon in developing countries and plaque buildup in coronary arteries, causing ischemic injury and arrhythmic episodes, is a vanishing mystery in its pathogenesis and emphasizing alternative routes for understanding and treatment of t [....] » Read More

Hamed Bazrafshan, Speaker at Cardiovascular Diseases Events
Oral Presentation
Hamed Bazrafshan, Shiraz University of Medical Sciences, Iran (Islamic Republic of)

Abstract: Background: SYNTAX score is one of the risk assessment systems to predict cardiac events in acute coronary syndrome patients. Despite the large number of SYNTAX score benefits, invasive methods such as coronary angiography are necessary to perform the scoring. We hypot [....] » Read More

 Kesha, Speaker at Cardio vascular conferences
Oral Presentation
Kesha, M S Ramaiah University of Applied Sciences, India

Myocardial Infarction (MI) related to cardiovascular diseases has been a major cause of death worldwide making it a challenge for the scientists to focus towards the protection of heart. The concept of Drug Repurposing showed Alpha-2 and Beta-1 adrenergic receptors having potent [....] » Read More

N Gokarneshan, Speaker at Heart Congress
Oral Presentation
N Gokarneshan, Hindustan Institute of Technology and Science, India

Due to a steadily growing number of patients and considerable diagnostic and therapeutic advances, vascular diseases are becoming more and more important in general and clinical practices. The design and fabrication of synthetic vascular prostheses have been challenging to the ar [....] » Read More

Namitha Aravind Baliga, Speaker at Speaker for CWC Conference- Namitha Aravind Baliga
Oral Presentation
Namitha Aravind Baliga, Manipal University, India

Abstract: Use of Ultrasound in non cardiac diagnosis like gynaecological scanning, abdominal scanning, renal ultrasound, pelvic ultrasound, chest ultrasound and soft tissue imaging of the neck, vascular ultrasound. A brief description about how an Echocardiographer can identify [....] » Read More

Pavel Ermolaev, Speaker at Speaker for CWC Conference- Pavel Ermolaev
Oral Presentation
Pavel Ermolaev, Omsk State Medical University, Russian Federation

The problem of preserving the viability of donor organs is relevant for clinical transplantation all over the world. The need for further development is associated with a global shortage of donor organs of ideal quality, with the need to prolong the terms of their guaranteed cons [....] » Read More

Pooja Sabherwal, Speaker at Cardiology Events
Oral Presentation
Pooja Sabherwal, The NorthCap University, India

In this paper, a novel algorithm for the accurate detection of QRS complex by combining the independent detection of R and S peaks, using fusion algorithm is proposed. R peak detection has been extensively studied and is being used to detect the QRS complex. Whereas, S peaks, whi [....] » Read More

Ausra Mongirdiene, Speaker at Cardiology Events
Oral Presentation
Ausra Mongirdiene, Lithuanian university of health sciences, Lithuania

HIT II is stated in the literature occurs in about 3% of all patients, and in 0,1%-5% of surgical patients. Thrombosis develops in 20%-64% of patients with HIT. Mortality rate in HIT II have not decreased using non-heparin treatment with anticoagulants like argatroban and lepirud [....] » Read More

Abeer Sarfaraz, Speaker at Cardiovascular Diseases Events
Oral Presentation
Abeer Sarfaraz, Liaquat National Hospital, Pakistan

Objective: To compare the levels of Pro-Bnp and Trop I to predict the dysfunction of the left ventricle in patients presenting with first Stemi. Methodology: It is an observational, cross-sectional, prospective, cohort study that was carried out in the cardiology department of [....] » Read More

Paula da Cruz Peniche, Speaker at Cardiovascular Conferences
Oral Presentation
Paula da Cruz Peniche, Universidade Federal de Minas Gerais , Brazil

Individuals after stroke have low levels of cardiorespiratory fitness (CRF) (maximum oxygen consumption (VO2max)). The CRF informs about the capacity of the cardiovascular and respiratory systems to supply blood rich in oxygen and about the capacity of the muscular system to use [....] » Read More

Tripti Sharma, Speaker at Cardiology Conferences
Oral Presentation
Tripti Sharma, USV Pvt Ltd, India

Background: There is an increase in number of hypertension patient in the Republic of Sri Lanka. Telmisartan is an angiotensin II receptor blocker & preferred as treatment of choice to achieve target blood pressure. Objective: The present study was conducted to evaluate th [....] » Read More

Ygal Plakht, Speaker at Cardiology Conferences
Oral Presentation
Ygal Plakht, Ben-Gurion University of the Negev , Israel

Background: Anemia has been shown to be adversely associated with outcomes following acute myocardial infarction (AMI). Anemia is often related to chronic kidney disease (CKD) which is prevalent among AMI patients. Aims: To evaluate the prognostic effect of anemia by different [....] » Read More

Ronak Chhaya, Speaker at Cardiovascular Conference
Oral Presentation
Ronak Chhaya, University of South Florida Academic Hospitalist, United States

Left ventricular noncompaction (LVNC) is a rare, congenital disorder affecting the lining of myocardial tissue. This distinct phenotype includes blood-filled trabeculations and deep recesses in the uncompressed endocardial wall with a thin, compact mesocardium. Clinical presentat [....] » Read More

Rishita Mondal, Speaker at Cardiovascular Conference
Oral Presentation
Rishita Mondal, Dr. Reddy's Laboratories, India

Background: Currently there’s lack of adequate medical expertise & facilities available in India for managing emergencies in ACS. According to the Cardiologists Society of India (CSI), there are only 5500 cardiologists available today in the country. Today with a pop [....] » Read More

Andrii Labchuk, Speaker at Cardiology Conferences
Oral Presentation
Andrii Labchuk, Advocate Lutheran General Hospital, United States

Cardiomyopathy is a known complication of tachyarrhythmias and carries a relatively favourable prognosis when rate control or reversal of the underlying cause is achieved. However, in pregnancy, it may be difficult to distinguish other more sinister causes of cardiomyopathy fro [....] » Read More

Elliot Jackson Smith, Speaker at Cardiology Conferences
Oral Presentation
Elliot Jackson Smith, Warwick Medical School, United Kingdom

Bioresorbable vascular scaffolds (BVS) are developed as a replacement for conventional drug-eluting stents (DES) used in percutaneous coronary intervention (PCI). They are designed to limit the accrual of late adverse events observed in DES by dissolving once they have restored l [....] » Read More

Sajjad Rezvan, Speaker at Cardiology Conferences
Oral Presentation
Sajjad Rezvan, MD, Radiology Resident, Iran (Islamic Republic of)

Circadian rhythms are known to affect human body in various ways and blood pressure is not an exception; normally blood pressure drops during the night. Hypertension is a common treatable and controllable disease that could lead to fatal complications via different mechanisms. [....] » Read More

Amirali Fallahian, Speaker at Cardiology Conferences
Oral Presentation
Amirali Fallahian, General Practitioner, Iran (Islamic Republic of)

Cardiovascular disease is the leading cause of death with most common etiology being coronary artery disease. Calcification in the intima and media layer of the vessel is of the first signs of of coronary artery involvement. On the other hand, end stage renal disease have been [....] » Read More

Timothy Abrahams, Speaker at Cardiovascular Conference
Oral Presentation
Timothy Abrahams, Monash Health, Australia

Introduction Heart Failure with Reduced Ejection Fraction (HFrEF) remains one of the leading causes of mortality worldwide and in Australia, and places significant burden on healthcare costs. Beta-Blockers are guideline therapy in HFrEF but it is unclear how this evidence has [....] » Read More

Angelo Rome Y Andaya, Speaker at Cardiovascular Conference
Oral Presentation
Angelo Rome Y Andaya, Philippine Heart Center, Philippines

Atrial Septal Defect (ASD) and Patent Ductus Arteriosus (PDA) are two of the most common congenital heart defects in adults but the combination of the two is rare and little is known regarding the proper timing of transcatheter closure of each when seen in one patient. I prese [....] » Read More

Ekaterina Konstantinova, Speaker at Cardiovascular Conference
Oral Presentation
Ekaterina Konstantinova, Pirogov Russian National Research Medical University, Russian Federation

To assess the severity of comorbid conditions in elderly patients with acute coronary syndrome (ACS) and to analyze subgroups with different treatment strategies for patients in the daily work of the Regional Vascular Center (RVC). Material and methods. The prospective study i [....] » Read More

Nikita Bastin, Speaker at Cardiology Conferences
Poster Presentation
Nikita Bastin, University of Pennsylvania, United States

Cardiovascular disease is a leading cause of mortality in prostate cancer patients1. Prostate cancer patients receiving androgen deprivation therapy (ADT), a standard treatment course for this population, are at higher risk for cardiovascular disease than patients whose treatment [....] » Read More

Shikha Jha, Speaker at Cardiovascular Events
Poster Presentation
Shikha Jha, Saint Peter's University Hospital, United States

Prolonged QTc interval is one of the critical risk factors for torsade de pointes and sudden cardiac death. QTc prolongation can be congenital or acquired. Medication side effects and electrolyte disturbances are two major acquired causes of a prolonged QTc interval. Case present [....] » Read More

Shikha Jha, Speaker at Cardiovascular Events
Poster Presentation
Shikha Jha, Saint Peter's University Hospital, United States

Triple vessel coronary artery disease is a life-threatening cardiovascular condition. Patients who are asymptomatic yet have a high pretest probability should undergo an appropriate diagnostic test before the occurrence of an adverse event. Case presentation: A 68-year-old male w [....] » Read More

Ibrahim Ahmed, Speaker at Cardiovascular Conferences
Poster Presentation
Ibrahim Ahmed, Mercy Catholic Medical Center, United States

Introduction: Cardiac sarcoidosis (CS) is a rare inflammatory condition affecting the myocardium. Frequently CS is associated with arrhythmias such as atrial flutter (AF). Our aim was to characterize the patient demographics of CS patients and investigate the effect of AF on CS. [....] » Read More

Stephanie Joppa, Speaker at Cardiology Conferences
Poster Presentation
Stephanie Joppa, Medical College of Wisconsin, United States

Intro: This is a case of a patient with previous left ventricular assist device (LVAD) pump thrombosis and prior pump exchange, who developed recurrent pump thrombosis refractory to medical treatment and was not a candidate for a re-do pump exchange. Case: A 57 year old wom [....] » Read More

Maurice Ilg, Speaker at Cardiovascular Conferences
Poster Presentation
Maurice Ilg, Technical University of Munich , Germany

Both ischemic (ICM) as non – ischemic cardiomyopathy (NICM) are associated with an increased risk of ventricular tachycardia (VT). In this study, we describe our experience with ablation of VT in patients with ICM and non ischemic cardimyopathy (NICM). Methods and result [....] » Read More

Oleg Sychov, Speaker at Heart Congress
Poster Presentation
Oleg Sychov, Strazhesko Institute of сardiology, Ukraine

Introduction: It is known that most patients with atrial fibrillation (AF) experience morphofunctional heart remodeling, and AF is one of the main causes of heart failure (HF). The aim of our study was to evaluate the course of HF, and to assess the state of intracardiac hemodyna [....] » Read More

Irena Mitevska, Speaker at Cardiovascular Conference
Poster Presentation
Irena Mitevska, University Cardiology Clinic, Macedonia, The Former Yugoslav Republic of

Pulmonary edema is one of the most serious complications of preeclampsia that should be ruled out in case of dyspnea in a pregnant woman. It is an indication of urgent pregnancy termination. The prognosis is generally good after adequate management and symptoms completely disappe [....] » Read More

Arvinjay Bautista, Speaker at Cardiology Conferences
Poster Presentation
Arvinjay Bautista, Cardinal Santos Medical Center, Philippines

Introduction: Studies show transthoracic 2D echocardiogram findings are varied in terms of right and left ventricular systolic function in COVID-19 patients. This three-month retrospective cohort analyzed 135 Severe and Critical COVID-19 adult patients admitted at Cardinal Santos [....] » Read More

Henrique Ulisses Duarte de Castro, Speaker at Cardiology Conferences
Poster Presentation
Henrique Ulisses Duarte de Castro, Faculty of Medical Sciences of Minas Gerais, Brazil

Abstract: Introduction: Heart failure (HF) is an extremely important clinical condition whose symptoms are the result of a structural or functional disorder of the heart. Heart transplantation is a complex and high-risk procedure, but when successfully performed demonstrates a [....] » Read More

Oksana Stasyshyna, Speaker at Heart Congress
Poster Presentation
Oksana Stasyshyna, Strazhesko Institute of сardiology, Ukraine

Introduction: It is known that the balance between sympathetic and parasympathetic regulation of the heart is characterized by indicators of heart rate variability (HRV). In patients with paroxysmal and persistent forms of atrial fibrillation (AF), HRV values ??may differ from no [....] » Read More

Hajra Munawar, Speaker at Cardiovascular Diseases Events
Poster Presentation
Hajra Munawar, University of Connecticut, United States

Background The utilization of extracorporeal membrane oxygenation (ECMO) as a rescue therapy for patients suffering from Covid 19 infection with respiratory failure remains controversial. According to the Extracorporeal life support organization registry, there are 13,126 patient [....] » Read More

 Alireza Sanei Motlagh, Speaker at Cardiovascular conferences
Poster Presentation
Alireza Sanei Motlagh, Mazandaran University of Medical Sciences, Iran (Islamic Republic of)

Background: Brain injury is one of the complications of open heart surgery. Glutamate plays a key role in this process. In this study, we evaluated the neuroprotective effect of memantine as NMDAR inhibitor in patients undergoing on-pump coronary artery bypass graft surgery (CABG [....] » Read More

Suryakanta Acharya, Speaker at Cardiology conferences
Poster Presentation
Suryakanta Acharya, Assam Cancer Care Foundation, PAY-W Clinic, India

Cardiac diseases and cancers constitute biggest chunk of NCD and can coexist. Hypertension is a common finding in elderly cancer patients, and many patients are either not on medication or not well controlled with medication. Arrythmia, MI are not so uncommon in elderly patients. [....] » Read More

Andreas Kristian, Speaker at Cardiology Conferences
Poster Presentation
Andreas Kristian, RSUD Cempaka Putih, Indonesia

Several studies and case reports have established an association between COVID-19 and ST segment elevation myocardial infarct (STEMI). AV conduction blockade or AV block is one of the STEMI complications. Patient COVID-19 with comorbid could become worsen suddenly clinically and [....] » Read More

Rayan Bushra, Speaker at Cardiovascular Conference
Poster Presentation
Rayan Bushra, Sudan Medical Specialization Board, Sudan

An atrioventricular block is a loss of the regular function of the cardiac electro conductive pathways. Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. The pacemaker stabilization of the cardiovascular system and hemodynamic variat [....] » Read More

Saule Urazalina, Speaker at  Cardiology Conferences
Poster Presentation (In-Person)
Saule Urazalina, Asfendiarov Kazakh National Medical University, Kazakhstan

A number of studies have shown that metabolic syndrome (MetS) is accompanied by an increase in arterial stiffness. In connection therewith, early detection of an increase in arterial stiffness in patients with MetS can help to prevent cardiovascular complications of them. Aim. To [....] » Read More

Saule Urazalina, Speaker at  Cardiology Conferences
Poster Presentation (In-Person)
Saule Urazalina, Asfendiarov Kazakh National Medical University, Kazakhstan

A number of studies have shown that metabolic syndrome (MetS) is accompanied by an increase in arterial stiffness. In connection therewith, early detection of an increase in arterial stiffness in patients with MetS can help to prevent cardiovascular complications of them. Aim. To [....] » Read More

Watsapp